| Source | Evidence on protein | Close homologs |
|---|---|---|
| Cuervo et al. | no | yes: 0 |
| Hassani et al. | no | yes: 0 |
| Forrest at al. (metacyclic) | no | yes: 0 |
| Forrest at al. (procyclic) | no | yes: 0 |
| Silverman et al. | no | yes: 0 |
| Pissara et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Pires et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Silverman et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Jamdhade et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| DeepLoc | ||
| SignalP6 | no | yes: 0, no: 9 |
| NetGPI | no | yes: 0, no: 9 |
| Term | Name | Level | Count |
|---|---|---|---|
| GO:0016020 | membrane | 2 | 9 |
| GO:0110165 | cellular anatomical entity | 1 | 9 |
| GO:0005886 | plasma membrane | 3 | 1 |
Related structures:
AlphaFold database: A4HL46
| Term | Name | Level | Count |
|---|---|---|---|
| GO:0000041 | transition metal ion transport | 7 | 1 |
| GO:0006810 | transport | 3 | 1 |
| GO:0006811 | monoatomic ion transport | 4 | 1 |
| GO:0006812 | monoatomic cation transport | 5 | 1 |
| GO:0006829 | zinc ion transport | 8 | 1 |
| GO:0009987 | cellular process | 1 | 1 |
| GO:0030001 | metal ion transport | 6 | 1 |
| GO:0034220 | monoatomic ion transmembrane transport | 3 | 1 |
| GO:0051179 | localization | 1 | 1 |
| GO:0051234 | establishment of localization | 2 | 1 |
| GO:0055085 | transmembrane transport | 2 | 1 |
| GO:0071577 | zinc ion transmembrane transport | 6 | 1 |
| GO:0098655 | monoatomic cation transmembrane transport | 4 | 1 |
| GO:0098660 | inorganic ion transmembrane transport | 4 | 1 |
| GO:0098662 | inorganic cation transmembrane transport | 5 | 1 |
| Term | Name | Level | Count |
|---|---|---|---|
| GO:0005215 | transporter activity | 1 | 2 |
| GO:0005385 | zinc ion transmembrane transporter activity | 7 | 1 |
| GO:0008324 | monoatomic cation transmembrane transporter activity | 4 | 2 |
| GO:0015075 | monoatomic ion transmembrane transporter activity | 3 | 2 |
| GO:0015318 | inorganic molecular entity transmembrane transporter activity | 3 | 2 |
| GO:0022857 | transmembrane transporter activity | 2 | 2 |
| GO:0022890 | inorganic cation transmembrane transporter activity | 4 | 2 |
| GO:0046873 | metal ion transmembrane transporter activity | 5 | 2 |
| GO:0046915 | transition metal ion transmembrane transporter activity | 6 | 1 |
| Leishmania | From | To | Domain/Motif | Score |
|---|---|---|---|---|
| CLV_C14_Caspase3-7 | 197 | 201 | PF00656 | 0.543 |
| CLV_C14_Caspase3-7 | 77 | 81 | PF00656 | 0.290 |
| CLV_NRD_NRD_1 | 14 | 16 | PF00675 | 0.425 |
| CLV_PCSK_KEX2_1 | 14 | 16 | PF00082 | 0.464 |
| CLV_PCSK_SKI1_1 | 216 | 220 | PF00082 | 0.291 |
| DEG_APCC_DBOX_1 | 252 | 260 | PF00400 | 0.398 |
| DEG_APCC_DBOX_1 | 299 | 307 | PF00400 | 0.482 |
| DOC_CKS1_1 | 228 | 233 | PF01111 | 0.403 |
| DOC_CYCLIN_RxL_1 | 211 | 220 | PF00134 | 0.490 |
| DOC_CYCLIN_yCln2_LP_2 | 228 | 234 | PF00134 | 0.368 |
| DOC_MAPK_MEF2A_6 | 171 | 180 | PF00069 | 0.501 |
| DOC_PP4_FxxP_1 | 219 | 222 | PF00568 | 0.491 |
| DOC_USP7_MATH_1 | 123 | 127 | PF00917 | 0.756 |
| DOC_USP7_MATH_1 | 205 | 209 | PF00917 | 0.650 |
| DOC_USP7_MATH_1 | 265 | 269 | PF00917 | 0.567 |
| DOC_USP7_MATH_1 | 284 | 288 | PF00917 | 0.312 |
| DOC_WW_Pin1_4 | 227 | 232 | PF00397 | 0.363 |
| DOC_WW_Pin1_4 | 271 | 276 | PF00397 | 0.391 |
| DOC_WW_Pin1_4 | 75 | 80 | PF00397 | 0.412 |
| LIG_14-3-3_CanoR_1 | 20 | 25 | PF00244 | 0.663 |
| LIG_14-3-3_CanoR_1 | 206 | 210 | PF00244 | 0.599 |
| LIG_14-3-3_CanoR_1 | 267 | 275 | PF00244 | 0.352 |
| LIG_14-3-3_CanoR_1 | 35 | 45 | PF00244 | 0.660 |
| LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.561 |
| LIG_BRCT_BRCA1_1 | 286 | 290 | PF00533 | 0.312 |
| LIG_Clathr_ClatBox_1 | 150 | 154 | PF01394 | 0.564 |
| LIG_CSL_BTD_1 | 6 | 9 | PF09270 | 0.569 |
| LIG_CtBP_PxDLS_1 | 68 | 72 | PF00389 | 0.256 |
| LIG_FHA_1 | 144 | 150 | PF00498 | 0.597 |
| LIG_FHA_1 | 20 | 26 | PF00498 | 0.773 |
| LIG_FHA_1 | 317 | 323 | PF00498 | 0.303 |
| LIG_FHA_1 | 40 | 46 | PF00498 | 0.623 |
| LIG_FHA_2 | 112 | 118 | PF00498 | 0.641 |
| LIG_FHA_2 | 188 | 194 | PF00498 | 0.537 |
| LIG_FHA_2 | 75 | 81 | PF00498 | 0.494 |
| LIG_LIR_Gen_1 | 287 | 298 | PF02991 | 0.416 |
| LIG_LIR_Gen_1 | 43 | 53 | PF02991 | 0.532 |
| LIG_LIR_Nem_3 | 287 | 293 | PF02991 | 0.328 |
| LIG_LIR_Nem_3 | 43 | 49 | PF02991 | 0.549 |
| LIG_Pex14_1 | 215 | 219 | PF04695 | 0.485 |
| LIG_Pex14_1 | 7 | 11 | PF04695 | 0.620 |
| LIG_Pex14_2 | 8 | 12 | PF04695 | 0.486 |
| LIG_REV1ctd_RIR_1 | 9 | 15 | PF16727 | 0.605 |
| LIG_SH2_PTP2 | 292 | 295 | PF00017 | 0.368 |
| LIG_SH2_STAT5 | 292 | 295 | PF00017 | 0.368 |
| LIG_SH3_3 | 10 | 16 | PF00018 | 0.586 |
| LIG_SH3_3 | 258 | 264 | PF00018 | 0.420 |
| LIG_SH3_3 | 3 | 9 | PF00018 | 0.547 |
| LIG_SH3_3 | 89 | 95 | PF00018 | 0.383 |
| LIG_Sin3_3 | 157 | 164 | PF02671 | 0.481 |
| LIG_SUMO_SIM_anti_2 | 133 | 139 | PF11976 | 0.550 |
| LIG_SUMO_SIM_anti_2 | 274 | 280 | PF11976 | 0.372 |
| LIG_TRAF2_1 | 116 | 119 | PF00917 | 0.598 |
| LIG_TRAF2_1 | 190 | 193 | PF00917 | 0.571 |
| LIG_TRAF2_1 | 299 | 302 | PF00917 | 0.474 |
| MOD_CK1_1 | 126 | 132 | PF00069 | 0.665 |
| MOD_CK1_1 | 268 | 274 | PF00069 | 0.430 |
| MOD_CK1_1 | 40 | 46 | PF00069 | 0.584 |
| MOD_CK1_1 | 75 | 81 | PF00069 | 0.461 |
| MOD_CK2_1 | 111 | 117 | PF00069 | 0.759 |
| MOD_CK2_1 | 185 | 191 | PF00069 | 0.577 |
| MOD_CK2_1 | 296 | 302 | PF00069 | 0.306 |
| MOD_GlcNHglycan | 125 | 128 | PF01048 | 0.508 |
| MOD_GlcNHglycan | 130 | 133 | PF01048 | 0.389 |
| MOD_GlcNHglycan | 161 | 164 | PF01048 | 0.395 |
| MOD_GlcNHglycan | 286 | 289 | PF01048 | 0.312 |
| MOD_GlcNHglycan | 326 | 329 | PF01048 | 0.570 |
| MOD_GlcNHglycan | 39 | 42 | PF01048 | 0.372 |
| MOD_GlcNHglycan | 53 | 56 | PF01048 | 0.342 |
| MOD_GlcNHglycan | 74 | 77 | PF01048 | 0.638 |
| MOD_GSK3_1 | 126 | 133 | PF00069 | 0.598 |
| MOD_GSK3_1 | 19 | 26 | PF00069 | 0.639 |
| MOD_GSK3_1 | 33 | 40 | PF00069 | 0.631 |
| MOD_GSK3_1 | 74 | 81 | PF00069 | 0.433 |
| MOD_NEK2_1 | 323 | 328 | PF00069 | 0.489 |
| MOD_NEK2_1 | 33 | 38 | PF00069 | 0.665 |
| MOD_NEK2_1 | 45 | 50 | PF00069 | 0.372 |
| MOD_NEK2_1 | 98 | 103 | PF00069 | 0.647 |
| MOD_PKA_2 | 123 | 129 | PF00069 | 0.600 |
| MOD_PKA_2 | 19 | 25 | PF00069 | 0.695 |
| MOD_PKA_2 | 205 | 211 | PF00069 | 0.642 |
| MOD_PKA_2 | 266 | 272 | PF00069 | 0.371 |
| MOD_PKA_2 | 34 | 40 | PF00069 | 0.632 |
| MOD_Plk_1 | 98 | 104 | PF00069 | 0.599 |
| MOD_Plk_2-3 | 111 | 117 | PF00069 | 0.594 |
| MOD_Plk_4 | 20 | 26 | PF00069 | 0.660 |
| MOD_Plk_4 | 274 | 280 | PF00069 | 0.437 |
| MOD_Plk_4 | 286 | 292 | PF00069 | 0.366 |
| MOD_Plk_4 | 293 | 299 | PF00069 | 0.331 |
| MOD_ProDKin_1 | 227 | 233 | PF00069 | 0.363 |
| MOD_ProDKin_1 | 271 | 277 | PF00069 | 0.382 |
| MOD_ProDKin_1 | 75 | 81 | PF00069 | 0.407 |
| MOD_SUMO_rev_2 | 299 | 306 | PF00179 | 0.511 |
| TRG_DiLeu_BaLyEn_6 | 29 | 34 | PF01217 | 0.558 |
| TRG_ENDOCYTIC_2 | 292 | 295 | PF00928 | 0.368 |
| TRG_ER_diArg_1 | 13 | 15 | PF00400 | 0.652 |
| TRG_ER_diArg_1 | 211 | 214 | PF00400 | 0.540 |
| TRG_ER_diArg_1 | 30 | 33 | PF00400 | 0.725 |
| TRG_Pf-PMV_PEXEL_1 | 216 | 220 | PF00026 | 0.443 |
| Protein | Taxonomy | Sequence identity | Coverage |
|---|---|---|---|
| A0A0N0P5U6 | Leptomonas seymouri | 47% | 95% |
| A0A1X0P3V2 | Trypanosomatidae | 29% | 75% |
| A0A3R7MSD3 | Trypanosoma rangeli | 34% | 100% |
| A0A3S7X6D4 | Leishmania donovani | 69% | 100% |
| A4I8M5 | Leishmania infantum | 69% | 100% |
| C9ZPV0 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 31% | 90% |
| E9B3I7 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 69% | 100% |
| Q4Q4L3 | Leishmania major | 68% | 100% |